Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 02, 2019 07:00 ET | Source: Kamada Ltd.

Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018

Full-Year 2018 Revenue Expected to be Between $113 Million and $115 Million Anticipated Revenues Exceed Current Revenue Guidance of $102 Million to $108 Million Expected Full-Year 2018 Total Revenue...
November 12, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Reports Financial Results for Third Quarter and First Nine Months of 2018

Total Revenues for First Nine Months of 2018 were $66.3 Million, a 1% Decrease Year-Over-YearGross Profit for First Nine Months of 2018 was $20.2 million, a 1% Decrease Year-Over-Year Adjusted EBITDA...
November 05, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on November 12

REHOVOT, Israel, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for...
October 22, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Announces Appointment of Life Sciences Industry Executive Eitan Kyiet as Vice President of Business Development

REHOVOT, Israel, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced today the appointment of Eitan Kyiet as Vice...
September 25, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

REHOVOT, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief Executive Officer,...
September 05, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Announces Extension of Collaboration with Massachusetts General Hospital for a Proof-of-Concept Study Evaluating the Potential Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation

REHOVOT, Israel, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced the extension of an ongoing...
August 29, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Provides Updated Full-Year 2018 Revenue Guidance

As result of the recent labor strike part of 2018 shipments are likely to be delayed to early 2019 Subsequent update and full-year 2019 revenue guidance to be provided later this year REHOVOT,...
August 16, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Announces the End of the Labor Strike in the Company’s Manufacturing Facility; All Employees Returned to Work

REHOVOT, Israel, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a plasma-derived protein therapeutics company, today announced that on August 15, 2018, the Company, the...
August 07, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

Total Revenues for Second Quarter were $33.8 Million, a 4% Increase Over Second Quarter of 2017Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017Gross...
August 01, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7

REHOVOT, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for...